FDA Approves Pimicotinib for TGCT Following Positive Phase 3 MANEUVER Trial Results
Joe Biden Says Prostate Cancer Is Slowing Him Down Ahead of Memoir Release
Beyond EGFR Mutations: New Study Reveals Why Some Lung Cancer Cells Survive Osimertinib
Breast Cancer in Michelangelo’s Sistine Chapel? A 500-Year-Old Fresco Sparks a Modern Medical Debate
Kate Middleton Opens Up About Cancer Recovery: Why Healing Is Not Always Linear
We Live in Time: When Cancer Changes the Meaning of Time
Paolo Tarantino: Individualizing T-DXd Treatment Duration in HER2-Positive Breast Cancer
Preoperative Single-Fraction and Fractionated Stereotactic Radiotherapy Show Comparable Outcomes in Resectable Brain Metastases
OncoDaily RT is the dedicated radiation oncology platform of OncoDaily, focused on the rapidly evolving field of radiotherapy and cancer treatment. It covers clinical research, treatment advances, technology, education, and global collaboration, including precision radiotherapy, stereotactic radiotherapy, brachytherapy, adaptive radiotherapy, proton therapy, artificial intelligence, treatment toxicity, survivorship, patient-centered care, and integration with systemic treatments. Through OncoDaily RT, radiation oncologists, medical physicists, researchers, trainees, industry partners, and multidisciplinary cancer care professionals can follow the latest research, emerging technologies, treatment innovations, congress updates, expert perspectives, interviews, articles, social media coverage, and expert-led discussions, while sharing knowledge and advancing radiation oncology worldwide.
